IL-3 Is a Novel Target to Interfere With Tumor Vasculature

Oncogene - United Kingdom
doi 10.1038/onc.2011.204
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC